Vogenx Statistics
NASDAQ: VOGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.87-0.935 (-7.30%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Vogenx by the numbers
Vogenx has a market capitalization of $176.3 million based on 14.86M shares outstanding. With trailing EPS of $-0.89, Vogenx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 41.2% below its 50-day average and 47.1% below its 200-day average.
Average daily trading volume is 128.78K shares, or about $1.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VOGX valuation vs. peer median
| Metric | VOGX | Peer median | Difference |
|---|---|---|---|
| Market cap | $176.33M | $178.23M | -1% |
| Avg. volume | 128.78K | 267.35K | -52% |
Peer median across 8 companies: NATR, ADCT, SIGA, SLGL, WHWK, TRDA, KRRO, RNAC.
Valuation
- Market cap
- $176.33M
- EPS (TTM)
- $-0.89
- Shares outstanding
- 14.86M
Price and trading
- Previous close
- 12.81
- Open
- 13.30
- Day range
- 11.87 – 13.30
- 52-week range
- 11.51 – 38.41
- Beta
- —
- Volume
- 100.91K
- Average volume
- 128.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 176.33M
- Eps
- -0.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 38.41
- Week52 Low
- 11.51
- Avg Volume
- 128.78K
- Shares Outstanding
- 14.86M
- Ma50
- 20.20
- Ma200
- 22.42
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -69.10%
- Pct From52w Low
- 3.13%